Search Results - "Musson, D."

Refine Results
  1. 1

    Using extended reality (XR) for medical training and real-time clinical support during deep space missions by Burian, B.K., Ebnali, M., Robertson, J.M., Musson, D., Pozner, C.N., Doyle, T., Smink, D.S., Miccile, C., Paladugu, P., Atamna, B., Lipsitz, S., Yule, S., Dias, R.D.

    Published in Applied ergonomics (01-01-2023)
    “…Medical events can affect space crew health and compromise the success of deep space missions. To successfully manage such events, crew members must be…”
    Get full text
    Journal Article
  2. 2

    Development of organic solvent‐free micro‐/nano‐porous polymer scaffolds for musculoskeletal regeneration by Lin, S. T. C., Musson, D. S., Amirapu, S., Cornish, J., Bhattacharyya, D.

    “…The use of biomaterial scaffolds has been an enormous field of research in tissue engineering, where the aim is to use graft materials for assisting the human…”
    Get full text
    Journal Article
  3. 3

    Pharmacokinetics of Ertapenem in Healthy Young Volunteers by MAJUMDAR, A. K, MUSSON, D. G, HAESEN, R, BLUM, R. A, LINS, R. L, GREENBERG, H, WALDMAN, S, DEUTSCH, P, ROGERS, J. D, BIRK, K. L, KITCHEN, C. J, HOLLAND, S, MCCREA, J, MISTRY, G, HESNEY, M, XI, L, LI, S. X

    Published in Antimicrobial Agents and Chemotherapy (01-11-2002)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Psychology and culture during long-duration space missions by Kanas, N., Sandal, G., Boyd, J.E., Gushin, V.I., Manzey, D., North, R., Leon, G.R., Suedfeld, P., Bishop, S., Fiedler, E.R., Inoue, N., Johannes, B., Kealey, D.J., Kraft, N., Matsuzaki, I., Musson, D., Palinkas, L.A., Salnitskiy, V.P., Sipes, W., Stuster, J., Wang, J.

    Published in Acta astronautica (01-04-2009)
    “…The objective of this paper is twofold: (a) to review the current knowledge of cultural, psychological, psychiatric, cognitive, interpersonal, and…”
    Get full text
    Journal Article
  6. 6

    Pharmacokinetics of Total and Unbound Ertapenem in Healthy Elderly Subjects by Musson, D G, Majumdar, A, Holland, S, Birk, K, Xi, L, Mistry, G, Sciberras, D, Muckow, J, Deutsch, P, Rogers, J D

    Published in Antimicrobial Agents and Chemotherapy (01-02-2004)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  7. 7

    Tissue Penetration by Ertapenem, a Parenteral Carbapenem Administered Once Daily, in Suction-Induced Skin Blister Fluid in Healthy Young Volunteers by LAETHEM, T, DE LEPELEIRE, I, DEUTSCH, P, MCCREA, J, ZHANG, J, MAJUMDAR, A, MUSSON, D, ROGERS, D, LI, S, GUILLAUME, M, PARNEIX-SPAKE, A

    Published in Antimicrobial Agents and Chemotherapy (01-04-2003)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Liquid chromatographic-tandem mass spectrometric urine assay for a highly metabolized cyclic ureidobenzenesulfonamide: issues concerning assay specificity and quality control preparation by Fisher, A.L, DePuy, E, Shih, T, Stearns, R, Lee, Y, Gottesdiener, K, Flattery, S, De Smet, M, Keymeulen, B, Musson, D.G

    “…An LC–MS–MS method was validated for the quantitation of a β 3 agonist ( A) in human urine to support Phase I studies. A was designed to accelerate metabolism…”
    Get full text
    Journal Article
  10. 10
  11. 11

    The personality profile of male Anglican clergy in England: The 16PF by Musson, David J.

    Published in Personality and individual differences (01-10-1998)
    “…The 16PF Questionnaire was completed by 441 male Anglican clergy of the Church of England who had taken part in Edward King Institute Ministerial Development…”
    Get full text
    Journal Article
  12. 12

    The effects of moclobemide on the pharmacokinetics of the 5‐HT1B/1D agonist rizatriptan in healthy volunteers by Van Haarst, A. D., Van Gerven, J. M. A., Cohen, A. F., De Smet, M., Sterrett, A., Birk, K. L., Fisher, A. L., De Puy, M. E., Goldberg, M. R., Musson, D. G.

    Published in British journal of clinical pharmacology (01-08-1999)
    “…Aims  The new 5‐HT1B/1D agonist rizatriptan (MK‐0462) has recently been registered for the treatment of migraine. Its primary route of metabolism is via…”
    Get full text
    Journal Article
  13. 13

    LC-MS/MS determination of a farnesyl transferase inhibitor in human plasma and urine by DePuy, M.E, Musson, D.G, Yu, S, Fisher, A.L

    “…To support clinical pharmacokinetic studies in cancer patients, sensitive and specific methods for measuring…”
    Get full text
    Journal Article
  14. 14

    Pharmacokinetics of rizatriptan in healthy elderly subjects by Musson, D G, Birk, K L, Panebianco, D L, Gagliano, K D, Rogers, J D, Goldberg, M R

    “…Rizatriptan is a serotonin 5-HT1B/1D receptor agonist for acute treatment of migraine. Its pharmacokinetics were assessed in healthy elderly males and females…”
    Get more information
    Journal Article
  15. 15

    Comparative disposition of [14C]ertapenem, a novel carbapenem antibiotic, in rat, monkey and man by Wong, B. K., Xu, X., Yu, S., Lin, J. H., Singh, R., Sahly, Y., Mistry, G., Holland, S., Waldman, S., Musson, D., Majumdar, A.

    Published in Xenobiotica (01-04-2004)
    “…The disposition and metabolism of ertapenem, a carbapenem antibiotic, was examined in rat, monkey and man. Sprague-Dawley rats and Rhesus monkeys were given,…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Characterization of the solubility of a poorly soluble hydroxylated metabolite in human urine and its implications for potential renal toxicity by Merschman, S A, Rose, M J, Pearce, G E S, Woolf, E J, Schaefer, B H, Huber, A C, Musson, D G, Perry, K J, Rush, D J, Varsolona, R J, Matuszewski, B K

    Published in Pharmazie (01-05-2005)
    “…The solubility, in human urine, of the major hydroxylated metabolite (M1) of an experimental cognition enhancer was characterized through a series of in vitro…”
    Get more information
    Journal Article
  18. 18

    Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies by Yeh, K C, August, T F, Bush, D F, Lasseter, K C, Musson, D G, Schwartz, S, Smith, M E, Titus, D C

    Published in Neurology (01-11-1989)
    “…The pharmacokinetics of Sinemet CR, a controlled-release formulation containing carbidopa and levodopa, were investigated in healthy young and elderly…”
    Get full text
    Journal Article
  19. 19
  20. 20

    High-throughput liquid chromatography for drug analysis in biological fluids: investigation of extraction column life by Zeng, Wei, Fisher, Alison L, Musson, Donald G, Wang, Amy Qiu

    “…A novel method was developed and assessed to extend the lifetime of extraction columns of high-throughput liquid chromatography (HTLC) for bioanalysis of human…”
    Get full text
    Journal Article